SAR and pharmacokinetic studies on phenethylamide inhibitors of the hepatitis C virus NS3/NS4A serine protease.

Bioorg Med Chem Lett

Department of Chemistry, Istituto di Ricerche di Biologia Molecolare, Merck Research Laboratories, Via Pontina Km 30.600, 00040 Pomezia, Rome, Italy.

Published: September 2004

SAR on the phenethylamide 1 (Ki 1.2 microM) in the P2- and the P'-position led to potent inhibitors, one of which showed good exposure and low clearance when administered intramuscularly to rat.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2004.05.093DOI Listing

Publication Analysis

Top Keywords

sar pharmacokinetic
4
pharmacokinetic studies
4
studies phenethylamide
4
phenethylamide inhibitors
4
inhibitors hepatitis
4
hepatitis virus
4
virus ns3/ns4a
4
ns3/ns4a serine
4
serine protease
4
protease sar
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!